| P2093 | author name string | Hirokazu Inoue | |
| | Yukihiro Tambe | |
| | Hiroyuki Sugihara | |
| | Ken-Ichi Mukaisho | |
| | Akihiro Kawauchi | |
| | Chul Jang Kim | |
| P2860 | cites work | Serrated lesions of the colorectum: review and recommendations from an expert panel | Q26827208 |
| | Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation | Q28140810 |
| | Targeting RAS signalling pathways in cancer therapy | Q28201363 |
| | Cyclin D as a therapeutic target in cancer | Q28242623 |
| | Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 |
| | Cyclin D1: polymorphism, aberrant splicing and cancer risk | Q28303053 |
| | The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 |
| | Targeting PI3K signalling in cancer: opportunities, challenges and limitations | Q29617685 |
| | PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells | Q33945648 |
| | Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation | Q34478869 |
| | PKB binding proteins. Getting in on the Akt. | Q34990565 |
| | Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck | Q35788347 |
| | Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept | Q36271250 |
| | Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management | Q37099611 |
| | Role of the serrated pathway in colorectal cancer pathogenesis | Q37737403 |
| | Update on the serrated pathway to colorectal carcinoma | Q37792441 |
| | The drs tumor suppressor regulates glucose metabolism via lactate dehydrogenase-B. | Q38916543 |
| | Female-specific rectal carcinogenesis in cyclin D1b transgenic mice | Q39105154 |
| | Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68 | Q39760025 |
| | Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells | Q39856793 |
| | D-type cyclins | Q40443885 |
| | An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene | Q40617469 |
| | Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation | Q42801826 |
| | Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 | Q59082348 |
| | Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers | Q73145251 |
| | The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241 | Q74063854 |
| | CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer | Q74379510 |
| P433 | issue | 6 | |
| P921 | main subject | neoplastic invasiveness | Q112498967 |
| P304 | page(s) | 4850-4856 | |
| P577 | publication date | 2016-10-18 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity | |
| P478 | volume | 12 | |